Conflict of Interest None of the committee members has any financial interest in any of the companies whose products are discussed here.
Guidelines for management of androgenetic alopecia based on BASP classification–the Asian consensus committee guideline
Article first published online: 23 NOV 2012
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology
Volume 27, Issue 8, pages 1026–1034, August 2013
How to Cite
Lee, W.S., Lee, H.J., Choi, G.S., Cheong, W.K., Chow, S.K., Gabriel, M.T., Hau, K.L., Kang, H., Mallari, M.R., Tsai, R.Y., Zhang, J. and Zheng, M. (2013), Guidelines for management of androgenetic alopecia based on BASP classification–the Asian consensus committee guideline. Journal of the European Academy of Dermatology and Venereology, 27: 1026–1034. doi: 10.1111/jdv.12034
Funding sources The publication of this article was financially supported in part by Merck Sharp & Dohme, Inc (MSD). However, MSD was not involved in any aspect of the planning, writing or editing of this manuscript before or after its publication. The comments, views and conclusions set out in the manuscript represent those of the authors, independent of any input or influence from MSD.
- Issue published online: 17 JUL 2013
- Article first published online: 23 NOV 2012
- Received: 5 June 2012; Accepted: 9 October 2012
Background Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furthermore, in comparison with Caucasian patients, Asian patients with AGA have different types of hair loss and family histories which may alter the treatment response. There is currently no published AGA guideline for Asian patients.
Objectives The Asian Consensus Committee for Androgenetic Alopecia aimed to develop an algorithmic guideline, based on the basic and specific (BASP) classification, for the treatment of AGA especially in Asian patients.
Methods The committee collaborated extensively on reviewing available literature on AGA treatment in order to formulate an algorithmic guideline on AGA management.
Results Previously published guidelines based on pre-existing classifications of AGA cannot easily classify the patterns of AGA that are more frequently seen in Asians. The BASP classification not only facilitates the development of a unified and simplified algorithm, but also overcomes the disadvantages of previously reported classification systems.
Conclusions The proposed treatment guideline for AGA based on the BASP classification may be useful for dermatologists in their approach to treating Asian patients with AGA in clinical practice. Ideally, clinicians should try to utilize this guideline consistently in their practice to monitor treatment response with the goal of enhancing successful outcomes. This will help boost patients' confidence and self-esteem, thus improving patients compliance with the prescribed treatments.